Does the media refer more to IART or HAE?

In the previous week, Integra LifeSciences and Integra LifeSciences both had 3 articles in the media. Integra LifeSciences' average media sentiment score of 1.31 beat Haemonetics' score of 0.98 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer LIVN or IART?

In the previous week, LivaNova had 7 more articles in the media than Integra LifeSciences. MarketBeat recorded 10 mentions for LivaNova and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.31 beat LivaNova's score of 1.00 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer IART or ITGR?

In the previous week, Integer had 6 more articles in the media than Integra LifeSciences. MarketBeat recorded 9 mentions for Integer and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.31 beat Integer's score of 0.38 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer IRTC or IART?

In the previous week, iRhythm Technologies and iRhythm Technologies both had 3 articles in the media. iRhythm Technologies' average media sentiment score of 1.57 beat Integra LifeSciences' score of 1.31 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Integra LifeSciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PLSE or IART?

In the previous week, Pulse Biosciences had 8 more articles in the media than Integra LifeSciences. MarketBeat recorded 11 mentions for Pulse Biosciences and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.31 beat Pulse Biosciences' score of 0.87 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Integra LifeSciences (IART) Competitors

$15.64 +0.14 (+0.90%)

As of 03:02 PM Eastern

Compare

IART vs. HAE, LIVN, ITGR, IRTC, and PLSE

Should you buy Integra LifeSciences stock or one of its competitors? Integra LifeSciences's main competitors and comparable companies include Haemonetics (HAE), LivaNova (LIVN), Integer (ITGR), iRhythm Technologies (IRTC), and Pulse Biosciences (PLSE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Integra LifeSciences compare to Haemonetics?

Integra LifeSciences (NASDAQ:IART) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Integra LifeSciences has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market. Comparatively, Haemonetics has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

Integra LifeSciences presently has a consensus price target of $18.86, suggesting a potential upside of 20.57%. Haemonetics has a consensus price target of $99.78, suggesting a potential downside of 6.47%. Given Integra LifeSciences' higher possible upside, equities analysts plainly believe Integra LifeSciences is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Integra LifeSciences and Integra LifeSciences both had 3 articles in the media. Integra LifeSciences' average media sentiment score of 1.31 beat Haemonetics' score of 0.98 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Haemonetics has lower revenue, but higher earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$0.09	N/A
Haemonetics	$1.33B	3.64	$97.31M	$2.04	52.29

Haemonetics has a net margin of 7.12% compared to Integra LifeSciences' net margin of -0.44%. Haemonetics' return on equity of 27.55% beat Integra LifeSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-0.44%	18.30%	5.30%
Haemonetics	7.12%	27.55%	9.65%

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by company insiders. Comparatively, 2.1% of Haemonetics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Haemonetics beats Integra LifeSciences on 11 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Integra LifeSciences (NASDAQ:IART) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

In the previous week, LivaNova had 7 more articles in the media than Integra LifeSciences. MarketBeat recorded 10 mentions for LivaNova and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.31 beat LivaNova's score of 1.00 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.6% of LivaNova shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 0.4% of LivaNova shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

LivaNova has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

LivaNova presently has a consensus target price of $84.13, suggesting a potential upside of 5.49%. Integra LifeSciences has a consensus target price of $18.86, suggesting a potential upside of 20.57%. Given Integra LifeSciences' higher possible upside, analysts clearly believe Integra LifeSciences is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

LivaNova has a net margin of 12.82% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat LivaNova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	12.82%	16.35%	7.76%
Integra LifeSciences	-0.44%	18.30%	5.30%

LivaNova has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.17	-$242.47M	$3.38	23.59
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$0.09	N/A

Summary

LivaNova beats Integra LifeSciences on 10 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to Integer?

Integra LifeSciences (NASDAQ:IART) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Integer has a net margin of 6.97% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-0.44%	18.30%	5.30%
Integer	6.97%	12.79%	6.48%

In the previous week, Integer had 6 more articles in the media than Integra LifeSciences. MarketBeat recorded 9 mentions for Integer and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.31 beat Integer's score of 0.38 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integra LifeSciences currently has a consensus price target of $18.86, suggesting a potential upside of 20.57%. Integer has a consensus price target of $109.86, suggesting a potential downside of 12.96%. Given Integra LifeSciences' higher probable upside, equities analysts clearly believe Integra LifeSciences is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Integra LifeSciences has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market. Comparatively, Integer has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 3.8% of Integra LifeSciences shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$0.09	N/A
Integer	$1.84B	2.33	$102.81M	$3.66	34.48

Summary

Integer beats Integra LifeSciences on 10 of the 15 factors compared between the two stocks.

How does Integra LifeSciences compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Integra LifeSciences (NASDAQ:IART) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

iRhythm Technologies has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market.

Integra LifeSciences has a net margin of -0.44% compared to iRhythm Technologies' net margin of -1.69%. Integra LifeSciences' return on equity of 18.30% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Integra LifeSciences	-0.44%	18.30%	5.30%

iRhythm Technologies currently has a consensus price target of $179.93, indicating a potential upside of 57.80%. Integra LifeSciences has a consensus price target of $18.86, indicating a potential upside of 20.57%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe iRhythm Technologies is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

In the previous week, iRhythm Technologies and iRhythm Technologies both had 3 articles in the media. iRhythm Technologies' average media sentiment score of 1.57 beat Integra LifeSciences' score of 1.31 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Integra LifeSciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has higher earnings, but lower revenue than Integra LifeSciences. iRhythm Technologies is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.03	-$44.55M	-$0.43	N/A
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$0.09	N/A

84.8% of Integra LifeSciences shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

iRhythm Technologies and Integra LifeSciences tied by winning 8 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and Integra LifeSciences (NASDAQ:IART) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

Pulse Biosciences has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market.

76.9% of Pulse Biosciences shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 74.0% of Pulse Biosciences shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Pulse Biosciences currently has a consensus price target of $45.25, indicating a potential downside of 17.21%. Integra LifeSciences has a consensus price target of $18.86, indicating a potential upside of 20.57%. Given Integra LifeSciences' higher possible upside, analysts clearly believe Integra LifeSciences is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

Integra LifeSciences has a net margin of -0.44% compared to Pulse Biosciences' net margin of -6,755.78%. Integra LifeSciences' return on equity of 18.30% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	-6,755.78%	-94.42%	-79.96%
Integra LifeSciences	-0.44%	18.30%	5.30%

Pulse Biosciences has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Pulse Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$1.19M	3,192.19	-$72.78M	-$1.18	N/A
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$0.09	N/A

In the previous week, Pulse Biosciences had 8 more articles in the media than Integra LifeSciences. MarketBeat recorded 11 mentions for Pulse Biosciences and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.31 beat Pulse Biosciences' score of 0.87 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulse Biosciences	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pulse Biosciences beats Integra LifeSciences on 9 of the 17 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IART vs. The Competition

Export

Metric	Integra LifeSciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.22B	$5.44B	$7.21B	$13.04B
Dividend Yield	N/A	1.80%	2.57%	11.71%
P/E Ratio	-173.81	25.02	274.15	25.47
Price / Sales	0.74	44.38	639.31	88.17
Price / Cash	3.67	33.03	28.42	34.96
Price / Book	1.17	6.02	10.43	6.26
Net Income	-$516.47M	$150.14M	$3.49B	$358.19M
7 Day Performance	-6.46%	-2.38%	-2.17%	-1.39%
1 Month Performance	-14.72%	-2.90%	0.54%	-2.63%
1 Year Performance	3.85%	9.64%	24.66%	8.70%

Integra LifeSciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IART Integra LifeSciences	2.5447 of 5 stars	$15.64 +0.9%	$18.86 +20.6%	+2.9%	$1.22B	$1.64B	N/A	4,427	Positive News
HAE Haemonetics	1.8388 of 5 stars	$102.46 -0.4%	$99.78 -2.6%	+96.5%	$4.65B	$1.33B	50.13	3,009	Gap Up
LIVN LivaNova	2.7386 of 5 stars	$80.57 -1.6%	$84.13 +4.4%	+39.1%	$4.43B	$1.39B	23.78	3,300
ITGR Integer	2.5387 of 5 stars	$126.40 -0.1%	$109.86 -13.1%	+24.2%	$4.30B	$1.84B	34.54	11,000	Options Volume
IRTC iRhythm Technologies	3.8992 of 5 stars	$120.65 -2.0%	$179.93 +49.1%	-38.0%	$3.97B	$747.14M	N/A	2,400	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IART) was last updated on 9/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integra LifeSciences (IART) Competitors

IART vs. HAE, LIVN, ITGR, IRTC, and PLSE

How does Integra LifeSciences compare to Haemonetics?

Summary

How does Integra LifeSciences compare to LivaNova?

Summary

How does Integra LifeSciences compare to Integer?

Summary

How does Integra LifeSciences compare to iRhythm Technologies?

Summary

How does Integra LifeSciences compare to Pulse Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART vs. The Competition

Integra LifeSciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integra LifeSciences (IART) Competitors

IART vs. HAE, LIVN, ITGR, IRTC, and PLSE

How does Integra LifeSciences compare to Haemonetics?

Which has more risk and volatility, IART or HAE?

Do analysts rate IART or HAE?

Does the media refer more to IART or HAE?

Which has higher valuation & earnings, IART or HAE?

Is IART or HAE more profitable?

Do institutionals and insiders have more ownership in IART or HAE?

Summary

How does Integra LifeSciences compare to LivaNova?

Does the media prefer LIVN or IART?

Do institutionals and insiders have more ownership in LIVN or IART?

Which has more risk & volatility, LIVN or IART?

Do analysts prefer LIVN or IART?

Is LIVN or IART more profitable?

Which has higher valuation and earnings, LIVN or IART?

Summary

How does Integra LifeSciences compare to Integer?

Is IART or ITGR more profitable?

Does the media prefer IART or ITGR?

Do analysts recommend IART or ITGR?

Which has more volatility and risk, IART or ITGR?

Do institutionals & insiders have more ownership in IART or ITGR?

Which has higher valuation & earnings, IART or ITGR?

Summary

How does Integra LifeSciences compare to iRhythm Technologies?

Which has more volatility & risk, IRTC or IART?

Is IRTC or IART more profitable?

Do analysts recommend IRTC or IART?

Does the media prefer IRTC or IART?

Which has stronger valuation & earnings, IRTC or IART?

Do institutionals and insiders believe in IRTC or IART?

Summary

How does Integra LifeSciences compare to Pulse Biosciences?

Which has more risk & volatility, PLSE or IART?

Do institutionals & insiders believe in PLSE or IART?

Do analysts prefer PLSE or IART?

Is PLSE or IART more profitable?

Which has higher valuation & earnings, PLSE or IART?

Does the media favor PLSE or IART?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART vs. The Competition

Integra LifeSciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools